Biosimilars: US and Europe COVID-19 and its economic impacts have only strengthened the case for further developing a sustainable global biosimilars market. In this Insights@CromosPharma paper we explore the development of the European biosimilar market and contrast this with the US. We also look at the key challenges and opportunities facing biosimilar developers. Cromos Pharma proudly supports the Right2hope nonprofit Read more
Clinical characteristics of dermatologic manifestations of COVID‐19 infection This article co-authored by Cromos Pharma CEO Dr Vlad Bogin and published in the International Journal of Dermatology (3 July 2020) examines the dermatologic manifestations of COVID-19. It includes a case series of 15 patients, review of literature, and proposed etiological classification. Read the full article here Cromos Pharma proudly supports the Right2hope nonprofit platform, empowering patients to explore treatment Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us